ISRG
Income statement / Annual
Last year (2024), Intuitive Surgical, Inc.'s total revenue was $8.35 B,
an increase of 17.24% from the previous year.
In 2024, Intuitive Surgical, Inc.'s net income was $2.32 B.
See Intuitive Surgical, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
Operating Revenue |
$8.35 B |
$7.12 B |
$6.22 B |
$5.71 B |
$4.36 B |
$4.48 B |
$3.72 B |
$3.13 B |
$2.70 B |
$2.38 B |
Cost of Revenue |
$2.72 B
|
$2.39 B
|
$2.03 B
|
$1.75 B
|
$1.50 B
|
$1.37 B
|
$1.12 B
|
$934.80 M
|
$814.30 M
|
$806.50 M
|
Gross Profit |
$5.63 B
|
$4.73 B
|
$4.20 B
|
$3.96 B
|
$2.86 B
|
$3.11 B
|
$2.60 B
|
$2.19 B
|
$1.89 B
|
$1.58 B
|
Gross Profit Ratio |
0.68
|
0.66
|
0.67
|
0.69
|
0.66
|
0.69
|
0.7
|
0.7
|
0.7
|
0.66
|
Research and Development Expenses |
$1.15 B
|
$998.80 M
|
$879.00 M
|
$671.00 M
|
$595.10 M
|
$557.30 M
|
$418.10 M
|
$328.60 M
|
$239.60 M
|
$197.40 M
|
General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$986.60 M
|
$810.90 M
|
$705.30 M
|
$640.50 M
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$2.14 B
|
$1.96 B
|
$1.74 B
|
$1.47 B
|
$1.22 B
|
$1.18 B
|
$986.60 M
|
$810.90 M
|
$705.30 M
|
$640.50 M
|
Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Operating Expenses |
$3.29 B
|
$2.96 B
|
$2.62 B
|
$2.14 B
|
$1.81 B
|
$1.74 B
|
$1.40 B
|
$1.14 B
|
$944.90 M
|
$837.90 M
|
Cost And Expenses |
-$6.00 B
|
$5.36 B
|
$4.65 B
|
$3.89 B
|
$3.31 B
|
$3.10 B
|
$2.52 B
|
$2.07 B
|
$1.76 B
|
$1.64 B
|
Interest Income |
$324.90 M
|
$192.10 M
|
$29.70 M
|
$69.30 M
|
$157.20 M
|
$116.80 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Interest Expense |
$0.00
|
$0.00
|
$29.70 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$324.90 M
|
$421.80 M
|
$380.40 M
|
$317.00 M
|
$282.50 M
|
$199.70 M
|
$120.10 M
|
$95.00 M
|
$88.90 M
|
$89.50 M
|
EBITDA |
$2.67 B |
$2.17 B |
$1.94 B |
$2.13 B |
$1.33 B |
$1.58 B |
$1.32 B |
$1.16 B |
$1.05 B |
$829.50 M |
EBITDA Ratio |
0.32
|
0.3
|
0.25
|
0.32
|
0.24
|
0.31
|
0.32
|
0.34
|
0.35
|
0.31
|
Operating Income Ratio |
0.28
|
0.25
|
0.19
|
0.32
|
0.18
|
0.31
|
0.32
|
0.34
|
0.35
|
0.31
|
Total Other Income/Expenses Net |
$324.90 M
|
$192.10 M
|
$29.70 M
|
$69.30 M
|
$157.20 M
|
$127.70 M
|
$80.10 M
|
$41.90 M
|
$35.60 M
|
$18.50 M
|
Income Before Tax |
$2.67 B
|
$1.96 B
|
$1.61 B
|
$1.89 B
|
$1.21 B
|
$1.50 B
|
$1.28 B
|
$1.10 B
|
$980.80 M
|
$758.50 M
|
Income Before Tax Ratio |
0.32
|
0.27
|
0.26
|
0.33
|
0.28
|
0.34
|
0.34
|
0.35
|
0.36
|
0.32
|
Income Tax Expense |
$336.30 M
|
$141.60 M
|
$262.40 M
|
$162.20 M
|
$140.20 M
|
$120.40 M
|
$154.50 M
|
$436.50 M
|
$244.90 M
|
$169.70 M
|
Net Income |
$2.32 B
|
$1.80 B
|
$1.32 B
|
$1.70 B
|
$1.06 B
|
$1.38 B
|
$1.13 B
|
$660.00 M
|
$735.90 M
|
$588.80 M
|
Net Income Ratio |
0.28
|
0.25
|
0.21
|
0.3
|
0.24
|
0.31
|
0.3
|
0.21
|
0.27
|
0.25
|
EPS |
6.5388 |
5.12 |
3.72 |
4.79 |
3.02 |
3.98 |
3.31 |
1.97 |
2.13 |
1.76 |
EPS Diluted |
6.42 |
5.03 |
3.65 |
4.66 |
2.94 |
3.85 |
3.16 |
1.89 |
2.08 |
1.73 |
Weighted Average Shares Out |
$355.20 M
|
$351.20 M
|
$355.70 M
|
$356.10 M
|
$351.00 M
|
$346.20 M
|
$341.10 M
|
$335.10 M
|
$344.70 M
|
$333.90 M
|
Weighted Average Shares Out Diluted |
$362.00 M
|
$357.40 M
|
$362.00 M
|
$365.80 M
|
$360.90 M
|
$358.50 M
|
$356.40 M
|
$348.90 M
|
$353.70 M
|
$341.10 M
|
Link |
|
|
|
|
|
|
|
|
|
|